The updated KDIGO heat map provides a practical framework for stratifying patient risk using eGFR and albuminuria to facilitate early detection and evidence-based management in primary care.
The increasing prevalence of type 2 diabetes is contributing substantially to chronic kidney and cardiovascular disease. The updated Kidney Disease: Improving Global Outcomes (KDIGO) heat map provides a practical framework for stratifying patient risk, using estimated glomerular filtration rate (eGFR) and albuminuria to facilitate early detection and evidence-based management. However, real-world adoption of the heat map remains limited. Integrating this tool into primary care and other subspecialities beyond nephrology can enhance individualized care. This review highlights the KDIGO guideline updates and provides an approach to implementing the heat map in primary care.
Galindo et al. (2026) conducted a review in Chronic kidney disease and type 2 diabetes. KDIGO heat map was evaluated. The updated KDIGO heat map provides a practical framework for stratifying patient risk using eGFR and albuminuria to facilitate early detection and evidence-based management in primary care.